SCOUT

A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

Larotrectinib (Vitrakvi, BAY2757556)OngoingActive not recruitingPhase 1Open NCT02637687 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…